Axsome Therapeutics (AXSM) Debt Ratio (2016 - 2026)

Axsome Therapeutics has disclosed Debt Ratio across 11 years of filings, most recently posting 0.18 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.18, down 43.22% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.18 (down 43.22% YoY), and the FY2025 annual result was 0.19, down 41.73% from the prior year.
• Debt Ratio came in at 0.18 for Q1 2026 at Axsome Therapeutics, down from 0.19 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.56 in Q1 2022 to a low of 0.18 in Q1 2026.
• The 5-year median for Debt Ratio is 0.31 (2023), against an average of 0.32.
• Peak annual rise in Debt Ratio reached 91.24% in 2022, while the deepest fall reached 45.97% in 2022.
• Axsome Therapeutics' Debt Ratio stood at 0.3 in 2022, then rose by 3.79% to 0.31 in 2023, then grew by 1.36% to 0.32 in 2024, then plunged by 41.73% to 0.19 in 2025, then dropped by 2.4% to 0.18 in 2026.
• The last three Debt Ratio figures came in at 0.18 (Q1 2026), 0.19 (Q4 2025), and 0.19 (Q3 2025), per Business Quant data.